Story thread · 3 reports / 3 sources
FDA Warns Pharmacy About Illegal GLP-1 Compounding
medpagetoday.com · 6h
How the coverage leans
Across 3 sources · syndicated copies counted once
(MedPage Today) -- The FDA issued a warning letter this month to Empower Pharmacy over its mass production of compounded GLP-1 weight-loss and diabetes drugs, citing illegal copycat manufacturing and insanitary conditions. Following a facility...
First report: Compounder Empower receives FDA warning letter over GLP-1s — endpts.com, 1d
The coverage
- FDA flags sterility concerns at major GLP-1 compounder
beckershospitalreview.com · 13h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.